Compositions useful for modulating splicing
AssigneeSkyhawk Therapeutics, Inc.
InventorsHasane RATNI, Ingo KONETZKI, Brian LUCAS, Michael LUZZIO
Life of this patent
Estimating the term…
Abstract
The present application discloses compounds of Formula (I) that modulate splicing of a pre-mRNA, encoded by genes, and methods of treating diseases and conditions associated with gene expression or activity of proteins encoded by genes, such as Spinocerebellar Ataxia 3 (SCA3 or Machado-Joseph Disease).
Claims21
A compound of Formula (I), or a pharmaceutically acceptable salt thereof:
- wherein,
- R21 is thiophenyl, which is unsubstituted or substituted with 1, 2, or 3, independently selected R1A groups;
- each R1A is independently selected from halo, CN, NO2, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C1-6 alkoxy, —C(═O)OH, —C(═O)C1-6 alkyl, —C(═O)C1-6 haloalkyl, and —C(═O)C1-6 alkoxy
- R23 is selected from the group consisting of H, azido, halo, CN, NO2, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 heteroalkyl, —(C1-6 alkylene)-C3-10 cycloalkyl, —(C1-6 alkylene)-4-10 membered heterocycloalkyl, —(C1-6 heteroalkylene)-C3-10 cycloalkyl, —(C1-6 heteroalkylene)-4-10 membered heterocycloalkyl, C3-10 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, ORa3, SRa3, C(═O)Rb3, C(═O)ORb3, NRc3Rd3, C(═O)NRc3Rd3, —OC(═O)NRc3Rd3, NRc3C(═O)Rb3, NRc3C(═O)ORb3, NRc3C(═O)NRc3Rd3, NRc3S(═O)2Rb3, NRc3S(═O)2NRc3Rd3, S(O)NRc3Rd3, and S(O)2NRc3Rd3, wherein the C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 heteroalkyl, C1-6 alkylene, C1-6 heteroalkylene, C3-10 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl are each optionally substituted by 1, 2, 3, or 4 independently selected R20 groups;
- R24 is selected from the group consisting of H, azido, halo, CN, NO2, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, ORa4, C(═O)Rb4, C(═O)ORb4, NRc4Rd4, C(═O)NRc4Rd4, —OC(═O)NRc4Rd4, NRc4C(═O)Rb4, NRc4C(═O)ORb4, NRc4C(═O)NRc4Rd4, NRc4S(═O)2Rb4, NRc4S(═O)2NRc4Rd4, S(O)NRc4Rd4, and S(O)2NRc4Rd4, wherein the C1-6 alkyl, C3-10 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl are each optionally substituted by 1, 2, 3, or 4 independently selected R20 groups;
- each Ra3, Rb3, Rc3, Rd3, Ra4, Rb4, Rc4, and Rd4, is independently selected from the group consisting of H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 hydroxyalkyl, C1-6 haloalkyl, C1-6 alkoxy, —(C1-6 alkylene)-C1-6 alkoxy, C3-10 cycloalkyl, —(C1-6 alkylene)-C3-10 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl, wherein the C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-10 cycloalkyl, —(C1-6 alkylene)-C3-10 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, and 4-10 membered heterocycloalkyl are each optionally substituted by 1, 2, 3, or 4 independently selected R20 groups;
- or Rc3 and Rd3 together with the N atom to which they are connected, come together to form a 5-10 membered heteroaryl or 4-10 membered heterocycloalkyl ring, each optionally substituted by 1, 2, 3, or 4 independently selected R20 groups;
- or Rc4 and Rd4 together with the N atom to which they are connected, come together to form a 5-10 membered heteroaryl or 4-10 membered heterocycloalkyl ring, each optionally substituted by 1, 2, 3, or 4 independently selected R20 groups;
- and
- each R20 is independently selected from the group consisting of OH, SH, CN, NO2, halo, oxo, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 haloalkyl, C1-4 cyanoalkyl, C1-4 hydroxyalkyl, C1-4 alkoxy, —(C1-4 alkyl)-(C1-4 alkoxy), —(C1-4 alkoxy)-(C1-4 alkoxy), C1-4 haloalkoxy, C3-6 cycloalkyl, phenyl, 5-6 membered heteroaryl, 4-6 membered heterocycloalkyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, carbamyl, C1-4 alkylcarbamyl, di(C1-4 alkyl) carbamyl, carbamoyl, C1-4 alkylcarbamoyl, di(C1-4 alkyl) carbamoyl, C1-4 alkylcarbonyl, C1-4 alkoxycarbonyl, C1-4 alkylcarbonylamino, C1-4 alkylsulfonylamino, aminosulfonyl, C1-4 alkylaminosulfonyl, di(C1-4 alkyl)aminosulfonyl, aminosulfonylamino, C1-4 alkylaminosulfonylamino, di(C1-4 alkyl)aminosulfonylamino, aminocarbonylamino, C1-4 alkylaminocarbonylamino, di(C1-4 alkyl)aminocarbonylamino, and amidinyl.
The compound of any of the preceding claims, wherein R23 is substituted or unsubstituted C1-6 alkyl or substituted or unsubstituted C1-6 heteroalkyl.
A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is selected from Table 1.
A pharmaceutical composition comprising a compound of any one of the preceding claims, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient or carrier.
Dependencies are inferred from the claim text.